Amazon.com Takes Aim at Drug Prices
Goliath Internet retailer Amazon.com (NASDAQ: AMZN) may have taken another step toward disrupting the pharmacy market. According to reports, Amazon has obtained pharmacy wholesale licenses in multiple states. The news shook pharmacy retailers such as CVS Health (NYSE: CVS), and drug distributors like McKesson Corp. (NYSE: MCK). Will we all be getting our next prescriptions filled by Amazon.com?
Amazon has been flirting with pharmacy retail for a long time. Founder Jeff Bezos was a former board member of the now-defunct online pharmacy retailer Drugs.com, and Amazon itself was once a 40% owner of Drugstore.com. Ultimately, Drugstore.com was a failed attempt at shaking up pharmacy distribution, but lessons learned could be shaping the second attempt.
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Amazon.com Inc. Stock
Our community is currently high on Amazon.com Inc. with 208 Buy predictions and 7 Sell predictions.
As a result the target price of 258 € shows a slightly positive potential of 8.88% compared to the current price of 236.95 € for Amazon.com Inc..
